Papilocare Dosage/Direction for Use

Who Can Use Papilocare: The use of Papilocare is recommended in women (over 18 years of age) infected by the human papillomavirus (HPV), independently of whether they have virus-induced lesions (ASCUS Atypical Squamous Cells of Undetermined Significance or LSIL-Low-grade squamous intraepithelial lesion).
Mode of Use: The treatment duration is 6 months, which can be extended for longer based on the medical prescription. It is important to complete the full length of treatment in order to obtain the desired results.
It is recommended to start treatment after menstruation.
First month: One cannula should be applied per day, for 21 consecutive days, then taking the next 7 days off.
Following months (month 2 to 6): One cannula should be applied every other day for 21 days. The recommendation to pause treatment with Papilocare during menstruation has to do with patient comfort, and not because there is any clinical incompatibility.
Papilocare should ideally be used just before bedtime. Papilocare is compatible with the use of condoms.
How to Apply Papilocare: Papilocare is supplied in single-use vaginal cannulas. Any cannula that appears open or broken should be discarded. The cannula is designed to aid in the product's application. For application, patient should lie on her back. The cannula should be inserted into the vagina, then press to release its contents. Then, remove it from the vagina, while continuing to press the cannula, in order to not suction out the product already applied.
It is possible that a small amount of gel remains in the cannula. This does not mean that a dose less than that recommended has been administered, as the cannula releases a sufficient amount to cover the cervical-vaginal mucosa (3 mL). Once the cannula is used, it should be discarded. A cannula should not be reused nor shared between two patients.